ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	20/131	191/7206	1.64658301284e-10
ko04621	NOD-like receptor signaling pathway	18/131	157/7206	3.30217897145e-10
ko05164	Influenza A	17/131	167/7206	6.76271129038e-09
ko04380	Osteoclast differentiation	14/131	134/7206	1.14978894962e-07
ko05168	Herpes simplex infection	15/131	182/7206	9.00036651581e-07
ko04064	NF-kappa B signaling pathway	11/131	96/7206	1.1159623676e-06
ko05152	Tuberculosis	15/131	187/7206	1.27191848449e-06
ko04668	TNF signaling pathway	12/131	120/7206	1.56150237233e-06
ko04620	Toll-like receptor signaling pathway	11/131	100/7206	1.6850458921e-06
ko05161	Hepatitis B	14/131	173/7206	2.65187901689e-06
ko05162	Measles	11/131	120/7206	1.01457241198e-05
ko04622	RIG-I-like receptor signaling pathway	8/131	62/7206	1.42728208376e-05
ko04672	Intestinal immune network for IgA production	6/131	37/7206	4.71066336604e-05
ko04658	Th1 and Th2 cell differentiation	9/131	96/7206	5.61501388567e-05
ko04660	T cell receptor signaling pathway	10/131	124/7206	7.87500830049e-05
ko04623	Cytosolic DNA-sensing pathway	6/131	41/7206	8.58415889154e-05
ko04217	Necroptosis	12/131	178/7206	8.7505082025e-05
ko04210	Apoptosis	12/131	180/7206	9.74389832154e-05
ko05160	Hepatitis C	11/131	153/7206	9.80357792951e-05
ko05131	Shigellosis	8/131	82/7206	0.000110969929883
ko05167	Kaposi's sarcoma-associated herpesvirus infection	12/131	191/7206	0.000171291333928
ko05340	Primary immunodeficiency	5/131	30/7206	0.000181932850888
ko04662	B cell receptor signaling pathway	8/131	88/7206	0.000182684861021
ko05323	Rheumatoid arthritis	8/131	89/7206	0.000197701499792
ko05166	HTLV-I infection	15/131	292/7206	0.000248711372119
ko05145	Toxoplasmosis	9/131	126/7206	0.000450806026954
ko05321	Inflammatory bowel disease (IBD)	6/131	56/7206	0.000496043773988
ko04630	Jak-STAT signaling pathway	9/131	132/7206	0.000633796261741
ko05144	Malaria	5/131	45/7206	0.00125426107005
ko05132	Salmonella infection	7/131	98/7206	0.00195982536538
ko04612	Antigen processing and presentation	6/131	77/7206	0.00265532603903
ko04659	Th17 cell differentiation	7/131	106/7206	0.00306303988215
ko05133	Pertussis	6/131	87/7206	0.00488123088137
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/131	92/7206	0.00640448023537
ko04650	Natural killer cell mediated cytotoxicity	6/131	97/7206	0.00824769719592
ko05330	Allograft rejection	3/131	24/7206	0.0089896269091
ko04145	Phagosome	8/131	162/7206	0.00916855985453
ko05142	Chagas disease (American trypanosomiasis)	7/131	130/7206	0.00928492560741
ko05134	Legionellosis	5/131	74/7206	0.010888183467
ko05140	Leishmaniasis	5/131	75/7206	0.011500008473
ko05169	Epstein-Barr virus infection	9/131	206/7206	0.0125142770888
ko05320	Autoimmune thyroid disease	3/131	29/7206	0.0151957009115
ko05416	Viral myocarditis	4/131	55/7206	0.0174114046974
ko04657	IL-17 signaling pathway	5/131	87/7206	0.0207420590802
ko04666	Fc gamma R-mediated phagocytosis	6/131	122/7206	0.0234214156182
ko05150	Staphylococcus aureus infection	3/131	36/7206	0.0270928438688
ko05100	Bacterial invasion of epithelial cells	5/131	99/7206	0.0338577490722
ko05146	Amoebiasis	5/131	99/7206	0.0338577490722
ko05332	Graft-versus-host disease	2/131	18/7206	0.0414977532663
ko04932	Non-alcoholic fatty liver disease (NAFLD)	7/131	182/7206	0.0476401693739